Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Slowdown in global generics market growth

Executive Summary

Growth in global prescription generic sales slowed in the 12 months ended Sept. 2008 from a year earlier, as fierce competition in most major markets took a toll on pricing, IMS Health reports. Global audited sales grew 3.6 percent during the period to $78 billion, down from 11.4 percent growth for the 12 months ended Sept. 2007. The U.S., which is the world's largest generics market, had a 2.7 percent decline in the period, while volume increased 5.4 percent. Generic drugs now account for 63.7 percent of the total U.S. pharmaceutical market volume
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS050455

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel